Spinal muscular atrophy drug blocked in UK

By Ella Pickover
Updated August 14 2018 - 12:16pm, first published 12:13pm
Muscular atrophy sufferer Avery Ball, two, would benefit from a drug that's been rejected in the UK.
Muscular atrophy sufferer Avery Ball, two, would benefit from a drug that's been rejected in the UK.

A decision by UK health officials to reject a drug that treats a rare genetic disorder which can mean affected children do not live to their second birthday has been condemned by a charity.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options